Solvay Doubles Specialty Fluorinated Derivatives Production Capacity in France
News Sep 07, 2012
Solvay announced today it is doubling the production capacity for specialty fluorinated aliphatic derivatives at its plant in Salindres, France, to keep up with the growing demand in strategic markets, such as energy storage, electronics and pharmaceuticals. The Group is investing over EUR 10 million in the plant to double the capacity of the fluorinated aliphatic derivatives production line. The project’s first stage is currently underway and the first additional volumes will be available this month.
The Group decided to double production capacity for triflic acid and triflic anhydride (TA, TAA), as well as for Lithium bis(trifluoromethanesulfonyl)imide (LiTFSI), to meet the rapidly expanding requirements of electronic applications (such as antistatic applications for flat screens, ionic liquids and liquid crystals), the battery market (for automobiles and computers) and the pharmaceuticals market.
“This capacity expansion is strengthening the role of our Salindres plant as a major production site for innovative fluorinated aliphatic derivatives,” commented Alessandro Chiovato, General Manager of the Crop Protection, Health & Electronics business at Solvay's Global Business Unit Rhodia Aroma Performance. “It will bring us in a better position to support the growth of our customers in all regions,” he added.
Scientists Report The Development of a Potent New Medicine to Fight AddictionNews
Scientists report the development of a potent new medicine to fight addiction.READ MORE
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Evolution Threatens Efficient Bioproduction Scale-UpNews
The transition towards sustainable biobased chemical production is important for green growth, but productivity and yield of engineered cells frequently decrease in large industry-scale fermentation. According to a new study, the role of evolution has been underestimated in limiting bioprocesses.